Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Clinical Outcomes of Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma in a County Hospital System

Jun Yang Jiang, Chijioke Nze, Danielle Guffey, Rockbum Kim, Abiodun O. Ouyomi, Omar Rosales, Raka Bandyo, Akiva Diamond, Gustavo A. Rivero, Courtney Nicole Miller-Chism, Mark M. Udden, Martha P. Mims, Christopher R. Flowers, Ang Li, Purnima Sravanti Teegavarapu

Blood (2023) 142 (Supplement 1): 5140.

https://doi.org/10.1182/blood-2023-173927

Published: 2023

Journal Articles

Real-World Validation of the European Leukemia Network 2022 Risk Stratification in Acute Myelogenous Leukemia

Sarah Elizabeth Mudra, Paul Sackstein, Lacey Scott Williams, Garrett Diltz, Rachel Zemel, Ashwin Kumar, Purnima Sravanti Teegavarapu, Martha P. Mims, Catherine Lai, Kimberley Doucette, Gustavo A. Rivero

Blood (2023) 142 (Supplement 1): 4297.

https://doi.org/10.1182/blood-2023-189309

Published: 2023

Journal Articles

Investigating Racially Induced Metabolic and Genomic Signatures Mediating Inferior Survival in African Americans with Acute Myelogenous Leukemia

Lacey Scott Williams, Alexis K Williams, Sarah Elizabeth Mudra, Paul Sackstein, Garrett Diltz, Rachel Zemel, Purnima Sravanti Teegavarapu, Martha P. Mims, Kimberley Doucette, Catherine Lai, Gustavo A. Rivero

Blood (2023) 142 (Supplement 1): 4320.

https://doi.org/10.1182/blood-2023-190898

Published: 2023

Journal Articles

The Human Leukemia Immunopeptidome Is Driven By Pathogenic Molecular Variant Biotypes

Paul Sackstein, Garrett Diltz, Lacey Scott Williams, Rachel Zemel, Sarah Elizabeth Mudra, Anne S. Renteria, Olga Timofeeva, Kimberley Doucette, Purnima Sravanti Teegavarapu, Gustavo A. Rivero

Blood (2023) 142 (Supplement 1): 6007.

https://doi.org/10.1182/blood-2023-188078

Published: 2023

Journal Articles

Investigating Metabolic and Immunologic Consequences of Nucleotide Substitutions in Acute Myeloid Leukemia

Garrett Diltz, Paul Sackstein, Sarah Elizabeth Mudra, Lacey Scott Williams, Rachel Zemel, Kimberley Doucette, Purnima Sravanti Teegavarapu, Gustavo A. Rivero

Blood (2023) 142 (Supplement 1): 2932.

https://doi.org/10.1182/blood-2023-190591

Published: 2023

Journal Articles

Predictors of Inferior Survival in African American Patients with Diffuse Large B-Cell Lymphoma

Kevin Tang, Heidi M Krause, Nikhil Patel, Grace Hwang, Jason Lu, Martha P. Mims, Mark M. Udden, Courtney Nicole Miller-Chism, Gustavo Rivero, Purnima Sravanti Teegavarapu

Blood (2022) 140 (Supplement 1): 8101–8102.

https://doi.org/10.1182/blood-2022-168224

Published: 2022

Journal Articles

Inferior Outcome in Non-Adult Young Adolescent B-Cell Acute Lymphoblastic Leukemia Exhibiting Obesity

Karen Heyly Vallejo, Quetzali Hernandez, Jason Lu, Victor Itaí Urbalejo Ceniceros, Purnima Sravanti Teegavarapu, Gustavo Rivero, Nidia Paulina Zapata

Blood (2022) 140 (Supplement 1): 6042–6043.

https://doi.org/10.1182/blood-2022-157190

Published: 2022

Journal Articles

Uncovering Ethnic Genomic Disparities Associated with Inferior Outcome in African Americans Diagnosed with Acute Myelogenous Leukemia

Alexis K Williams, Sergio Abraham, Gianfranco Bittar, Diana De Oliveira, Purnima Sravanti Teegavarapu, Gustavo Rivero

Blood (2022) 140 (Supplement 1): 9128–9129.

https://doi.org/10.1182/blood-2022-159232

Published: 2022

Journal Articles

Dexamethasone during Leukemia Induction Therapy to Reduce Incidence of Acute Myelogenous Leukemia Relapse

Ashley Sidebottom, Hannah Otiker, Purnima Sravanti Teegavarapu, Gustavo Rivero, Grace Hwang

Blood (2022) 140 (Supplement 1): 9032–9033.

https://doi.org/10.1182/blood-2022-162768

Published: 2022

Journal Articles

Specific Nucleotide Substitutions and Stressors Erode Highly Conserved Genomic Regions in Acute Myelogenous Leukemia

Nikhil Patel, Gustavo Rivero, Martha P. Mims, Purnima Sravanti Teegavarapu, Gianfranco Bittar, Diana De Oliviera

Blood (2022) 140 (Supplement 1): 6112–6113.

https://doi.org/10.1182/blood-2022-171086

Published: 2022

Journal Articles

A Real-World Single-Institution Experience with Hypomethylating Agents Plus BCL-2 Inhibitor for the Treatment of Acute Myeloid Leukemia

Brandon J Kale, Grace Hwang, Purnima Sravanti Teegavarapu, Martha P. Mims, Gustavo Rivero

Blood (2022) 140 (Supplement 1): 8934–8935.

https://doi.org/10.1182/blood-2022-170210

Published: 2022

Journal Articles

Predictive Ability of Coronary Artery Disease on Age Acceleration and Clinical Outcome in Adult Acute Myelogenous Leukemia

Ximena Melhado Basurto, Gustavo Rivero, Carlos José Fajardo, Purnima Sravanti Teegavarapu, Nidia Paulina Zapata, Victor Itaí Urbalejo Ceniceros, Karen Heyly Vallejo

Blood (2022) 140 (Supplement 1): 11621–11622.

https://doi.org/10.1182/blood-2022-162314

Published: 2022

Journal Articles

Comorbidity Evaluation Identifies Smoking Dose Density to be Associated with TP53 Mutation in Myeloid Malignancies

Alexis K Williams, Iberia R. Sosa, Purnima Sravanti Teegavarapu, Gustavo Rivero

Blood (2021) 138 (Supplement 1): 4450.

https://doi.org/10.1182/blood-2021-151782

Published: 2021

Journal Articles

Tobacco Use Predicts Unique Mutagenesis Signature in Acute Myelogenous Leukemia

Tran Hoang, Gianfranco Bittar, Purnima Sravanti Teegavarapu, Martha P. Mims, Gustavo Rivero

Blood (2021) 138 (Supplement 1): 1297.

https://doi.org/10.1182/blood-2021-154173

Published: 2021

Journal Articles

Obesity Is Associated with Increased Relapse Risk in Diffuse Large B-Cell Lymphoma

Kevin Tang, Jorge Mazzini, Martha P. Mims, Gustavo Rivero, Purnima Sravanti Teegavarapu

Blood (2021) 138 (Supplement 1): 1449.

https://doi.org/10.1182/blood-2021-154153

Published: 2021

Journal Articles

Differential Induction Among Younger Patients Diagnosed with Secondary Acute Myelogenous Leukemia Is Feasible By Cytogenetic/Molecular Risk Stratification

Aimaz Afrough, MD, Rafee Talukder, MD, Sarvari Venkata Yellapragada, MD, Purnima Sravanti Teegavarapu, MD, Martha P. Mims, MD PhD, Gustavo A. Rivero, MD

Blood (2019) 134 (Supplement_1): 2678.

https://doi.org/10.1182/blood-2019-129183

Published: 2019

Journal Articles

Staphylococcus Species Leads the Eskape Infections in Various Hematological Malignancies

Purnima Sravanti Teegavarapu, MD, Mamta Puppala, MSc, Sai Ravi Pingali, MD, Asmita Patel, Ibrahim Ibrahim, MD, Akash Mukherjee, MD, Lawrence Rice, MD, Swaminathan Padmanabhan Iyer, MD

Blood (2015) 126 (23): 4623.

https://doi.org/10.1182/blood.V126.23.4623.4623

Published: 2015

NARROW

Clinical Outcomes of Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma in a County Hospital System

Real-World Validation of the European Leukemia Network 2022 Risk Stratification in Acute Myelogenous Leukemia

Investigating Racially Induced Metabolic and Genomic Signatures Mediating Inferior Survival in African Americans with Acute Myelogenous Leukemia

The Human Leukemia Immunopeptidome Is Driven By Pathogenic Molecular Variant Biotypes

Investigating Metabolic and Immunologic Consequences of Nucleotide Substitutions in Acute Myeloid Leukemia

Predictors of Inferior Survival in African American Patients with Diffuse Large B-Cell Lymphoma

Inferior Outcome in Non-Adult Young Adolescent B-Cell Acute Lymphoblastic Leukemia Exhibiting Obesity

Uncovering Ethnic Genomic Disparities Associated with Inferior Outcome in African Americans Diagnosed with Acute Myelogenous Leukemia

Dexamethasone during Leukemia Induction Therapy to Reduce Incidence of Acute Myelogenous Leukemia Relapse

Specific Nucleotide Substitutions and Stressors Erode Highly Conserved Genomic Regions in Acute Myelogenous Leukemia

A Real-World Single-Institution Experience with Hypomethylating Agents Plus BCL-2 Inhibitor for the Treatment of Acute Myeloid Leukemia

Predictive Ability of Coronary Artery Disease on Age Acceleration and Clinical Outcome in Adult Acute Myelogenous Leukemia

Comorbidity Evaluation Identifies Smoking Dose Density to be Associated with TP53 Mutation in Myeloid Malignancies

Tobacco Use Predicts Unique Mutagenesis Signature in Acute Myelogenous Leukemia

Obesity Is Associated with Increased Relapse Risk in Diffuse Large B-Cell Lymphoma

Differential Induction Among Younger Patients Diagnosed with Secondary Acute Myelogenous Leukemia Is Feasible By Cytogenetic/Molecular Risk Stratification

Staphylococcus Species Leads the Eskape Infections in Various Hematological Malignancies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only